Variations in bladder pain syndrome/interstitial cystitis (IC) definitions, pathogenesis, diagnostics and treatment: a systematic review and evaluation of national and international guidelines
- 357 Downloads
Introduction and hypothesis
Interstitial cystitis (IC) and bladder pain syndrome (BPS) are challenging and encompassing hypersensitivity disorders of the lower urinary tract. A variety of national and international guidelines have been published including guidance on nomenclature, definitions, etiopathology, diagnostics and treatment. A lack of universally established clinical guidance is apparent. The aim of this review is to evaluate key guidelines on this area of practice, identify variations, compare their recommendations and grade them using AGREE II.
Literature searches were performed using the PUBMED and CINAHL database from January 1, 1983, to December 1, 2018, referring to the search strategy of AUA. Ten national and international guidelines were included into the analysis. We assessed the guidelines with the updated AGREE II.
Symptoms congruent in all guidelines are: pain, pressure, discomfort and frequency, urgency and nocturia. Urinalysis is a prerequisite for diagnostics, cystoscopy for most and urodynamics not part of the routine assessment. Treatment options are recommended stepwise. The highest level of evidence and consensus was identified for oral therapies. Nine guidelines had an overall quality score ≥ 50% and three scored ≥ 70% (AUA, GG, RCOG).
The guidelines are congruent in symptom reporting, quite congruent in diagnostics and vary to a high degree on treatment recommendations. The complexity of BPS and emerging evidence indicate the need for regular updating of the guidelines and a wider consensus.
KeywordsBladder pain syndrome Interstitial cystitis Diagnostics Treatment Guidelines AGREE II
Compliance with ethical standards
Conflicts of interest
Details of ethics approval
There is no need for ethical approval for a systematic review.
- 3.Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J Urol. 2013;189(1):141–5. https://doi.org/10.1016/j.juro.2012.08.088.CrossRefPubMedGoogle Scholar
- 4.Davis NF, Gnanappiragasam S, Thornhill JA. Interstitial cystitis/painful bladder syndrome: the influence of modern diagnostic criteria on epidemiology and on internet search activity by the public. Transl Androl Urol. 2015;4(5):506–11. https://doi.org/10.3978/j.issn.2223-4683.2015.06.08.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7. https://doi.org/10.1016/j.eururo.2007.09.019.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Esteban M, Adot JM, Arlandis S, Peri L, Prieto L, Salinas J, et al. Recommendations for the diagnosis and management of bladder pain syndrome. Spanish Urological Association consensus document. Actas Urológicas Españolas (English Edition). 2015;39(8):465–72. https://doi.org/10.1016/j.acuroe.2015.07.002.CrossRefGoogle Scholar
- 17.Tirlapur SA, Ni Riordain R, Khan KS, Collaboration E-C. Variations in the reporting of outcomes used in systematic reviews of treatment effectiveness research in bladder pain syndrome. Eur J Obstet Gynecol Reprod Biol. 2014;180:61–7. https://doi.org/10.1016/j.ejogrb.2014.06.003.CrossRefPubMedGoogle Scholar
- 18.Mishra NN. Clinical presentation and treatment of bladder pain syndrome/interstitial cystitis (BPS/IC) in India. Transl Androl Urol. 2015;4(5):512–23. https://doi.org/10.3978/j.issn.2223-4683.2015.10.05.CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Wesselmann U. Chronic pelvic and urogenital pain syndromes. Pain. 2008;16(6):1–4.Google Scholar
- 20.Petrovic Z. Leitlinien Beckenschmerzsyndrom. J Urol Urogynäkol. 2012;19(4):15–21.Google Scholar
- 23.The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines. Bmj. 2016;354:i4852. https://doi.org/10.1136/bmj.i4852.
- 24.Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Updated by Howick J (March 2009). 2009. Available from: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.
- 26.Hanno PM. Bladder pain syndrome (interstitial cystitis) and related disorders. In: Wein AJ, Kavoussi LR, Novick AC, et al., editors. Campbell-Walsh urology. 7th ed. Philadelphia: Saunders; 1998.Google Scholar
- 30.Rapariz-Gonzalez M, Castro-Diaz D, Mejia-Rendon D. Evaluation of the impact of the urinary symptoms on quality of life of patients with painful bladder syndrome/chronic pelvic pain and radiation cystitis: EURCIS study. Actas Urol Esp. 2014;38(4):224–31. https://doi.org/10.1016/j.acuro.2013.09.016.CrossRefPubMedGoogle Scholar
- 31.Management of Bladder Pain Syndrome: Green-top Guideline No. 70. BJOG. 2017;124(2):e46–72. https://doi.org/10.1111/1471-0528.14310.
- 32.Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, et al. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type a for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol. 2008;53(6):1245–53. https://doi.org/10.1016/j.eururo.2008.02.037.CrossRefPubMedGoogle Scholar
- 35.Palacios JL, Juarez M, Moran C, Xelhuantzi N, Damaser MS, Cruz Y. Neuroanatomic and behavioral correlates of urinary dysfunction induced by vaginal distension in rats. American Journal of Physiology Renal Physiology. 2016;310(10):F1065–73. https://doi.org/10.1152/ajprenal.00417.2015.CrossRefPubMedGoogle Scholar
- 41.Okragly AJ, Niles AL, Saban R, Schmidt D, Hoffman RL, Warner TF, et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol. 1999;161(2):438–41 discussion 441-432.CrossRefGoogle Scholar
- 43.Chuang YC, Weng SF, Hsu YW, Huang CL, Wu MP. Increased risks of healthcare-seeking behaviors of anxiety, depression and insomnia among patients with bladder pain syndrome/interstitial cystitis: a nationwide population-based study. Int Urol Nephrol. 2015;47(2):275–81. https://doi.org/10.1007/s11255-014-0908-6.CrossRefPubMedGoogle Scholar
- 48.Kolata G. Program coaxes hospitals to see treatments under their noses. New York Times (December 25). 2004.Google Scholar